The protocol describes how to measure knee hyperalgesia in mice. We show examples in mouse models of acute knee pain as well as in models of osteoarthritis (OA).
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
The protocol describes how to measure knee hyperalgesia in mice. We show examples in mouse models of acute knee pain as well as in models of osteoarthritis (OA).
Assessment of knee hyperalgesia provides a robust assay for measuring peripheral sensitization in the knee, and represents a clinically relevant pain-dependent behavior that can be used in rodent models of arthritis. Several methods have been reported to determine the threshold for responses to knee compression in rodents. Here, we aimed to adapt existing methods to develop a standardized method for assessing knee hyperalgesia in adult mice, using a Pressure Application Measurement (PAM) device. The protocol includes detailed steps, training recommendations for new experimenters, and tips for achieving consistent results. We provide suggestions for optimal training of a new experimenter. Finally, representative outcomes are provided for both acute models of transient hyperalgesia and experimental osteoarthritis (OA) models, which are characterized by chronic pain. This method is highly sensitive to pharmacological interventions, making it suitable for evaluating the effects of mediators like cytokines and for medium-throughput drug screening assays. In summary, the described approach provides a robust and clinically relevant method for quantifying knee hyperalgesia.
Osteoarthritis (OA), the most common form of arthritis, is characterized by progressive cartilage degradation, synovitis, bone remodeling, and osteophyte growth1, and presents clinically as pain and loss of joint function. OA is one of the major sources of chronic pain in the world, profoundly impacting patients' lives due to reduced mobility and associated health issues such as anxiety and depression2,3. Commonly prescribed drugs for OA pain include nonsteroidal anti-inflammatory drugs (NSAIDs), visco-supplementation, corticosteroids, and opioids, but their efficacy is limited, and....
Access restricted. Please log in or start a trial to view this content.
All experimental protocols were approved under the category E by the Rush University Institutional Animal Care and Use Committee. The protocol described is to assess knee hyperalgesia in the right knee in response to a mechanical stimulus in adult C57BL/6 mice (10 weeks- 2 years of age) of either sex. To measure knee hyperalgesia in the left knee, switch hands.
1. Setting up the Pressure Application Measurement (PAM) device
Access restricted. Please log in or start a trial to view this content.
Time course of knee hyperalgesia in a model of acute knee pain
All results shown have been previously reported by our group, and we refer to10for a detailed description. The first example shows a model for inducing acute, transient knee hyperalgesia. In this experiment, we injected Pam3CSK4, a synthetic toll-like receptor 2 (TLR2) ligand (1 µg or 3 µg, dissolved in sterile water) at 5 µL, into the knee cavity of 10-week-old naïve male C57BL/6 mice, using a Hamilton syringe wit.......
Access restricted. Please log in or start a trial to view this content.
Measurement of knee hyperalgesia in mice offers a relatively fast and straightforward means of assessing knee hyperalgesia associated with experimental arthritis. As can be observed from the representative results shown, the assay can detect acute onset and transient hyperalgesia (Figure 2A). We have reported this behavior in response to several mediators injected into the knee joint, including an aggrecan fragment10, a neurotrophin, nerve growth factor (NGF)
Access restricted. Please log in or start a trial to view this content.
AMM is a consultant for Novartis, Merck, Roivant, and Averitas. She has received research support from Orion and Eli Lilly. SI and REM have nothing to disclose.
Our research is funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Numbers: P30AR079206 (AMM), R01AR060364 (AMM), R01AR064251 (AMM), UC2AR082186 (AMM), R21AR085242-01 (AMM), and R01AR077019 (REM).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| C-C chemokine 2 receptor antagonist (CCR2RA) | Tocris | RS 504393 | |
| computer (any type) | windows 7 minimum | ||
| Lidocaine | Sigma | L5647 | |
| Pressure Application Measurement (P.A.M) | Ugo Basile | 38500 | included transducer, computer, cables |
| sandwich bag | whole food market | 6-1/2 x 5-7/8 | cover the transducer |
| toll-like receptor 2 ligand Pam3CSK4 | invitrogen | tlrl-pms |
Access restricted. Please log in or start a trial to view this content.